CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients

BACKGROUND: The aim of this study was to evaluate the value of CA15-3 for the diagnostic integration of molecular imaging findings performed with hybrid positron emission tomography and computed tomography (PETCT) technology. METHODS: We retrospectively selected 45 patients with a median age of 60 y...

Descripción completa

Detalles Bibliográficos
Autores principales: Incoronato, Mariarosaria, Mirabelli, Peppino, Catalano, Onofrio, Aiello, Marco, Parente, Chiara, Soricelli, Andrea, Nicolai, Emanuele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038066/
https://www.ncbi.nlm.nih.gov/pubmed/24886519
http://dx.doi.org/10.1186/1471-2407-14-356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038066/
https://www.ncbi.nlm.nih.gov/pubmed/24886519
http://dx.doi.org/10.1186/1471-2407-14-356

Ejemplares similares